Literature DB >> 22345573

Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.

Anna A Birukova1, Yufeng Tian, Angelo Meliton, Alan Leff, Tinghuai Wu, Konstantin G Birukov.   

Abstract

Most patients with acute lung injury (ALI) and acute respiratory distress syndrome of septic and nonseptic nature require assisted ventilation with positive pressure, which at suboptimal range may further exacerbate lung dysfunction. Previous studies described enhancement of agonist-induced Rho GTPase signaling and endothelial cell (EC) permeability in EC cultures exposed to pathologically relevant cyclic stretch (CS) magnitudes. This study examined a role of pathologic CS in modulation of pulmonary EC permeability caused by IL-6, a cytokine increased in sepsis and acting in a Rho-independent manner. IL-6 increased EC permeability, which was associated with activation of Jak/signal transducers and activators of transcription, p38 MAP kinase, and NF-κB signaling and was augmented by EC exposure to 18% CS. Rho kinase inhibitor Y-27632 suppressed the synergistic effect of 18% CS on IL-6-induced EC monolayer disruption but did not alter the IL-6 effects on static EC culture. 18% CS also increased IL-6-induced ICAM-1 expression by pulmonary EC and neutrophil adhesion, which was attenuated by Y-27632. Intratracheal IL-6 administration in C57BL/6J mice increased protein content and cell count in bronchoalveolar lavage fluid. These changes were augmented by high tidal volume mechanical ventilation (HTV; 30 ml/kg, 4 h). Intravenous injection of Y-27632 suppressed IL6/HTV-induced lung injury. In conclusion, this study proposes a novel mechanism contributing to two-hit model of ALI: in addition to synergistic effects on Rho-dependent endothelial hyper-permeability triggered by thrombin, TNFα, LPS, or other agonists, ventilator-induced lung injury-relevant CS may also exacerbate Rho-independent mechanisms of EC permeability induced by other inflammatory mediators such as IL-6 via mechanisms involving Rho activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345573      PMCID: PMC3362159          DOI: 10.1152/ajplung.00292.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  42 in total

1.  Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632.

Authors:  Sadatomo Tasaka; Hidefumi Koh; Wakako Yamada; Mie Shimizu; Yuko Ogawa; Naoki Hasegawa; Kazuhiro Yamaguchi; Yoshiki Ishii; Sarah E Richer; Claire M Doerschuk; Akitoshi Ishizaka
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

Review 2.  Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

3.  Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts.

Authors:  Guoguang Yang; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2005-10-13       Impact factor: 3.688

4.  Lung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.

Authors:  Anna A Birukova; Panfeng Fu; Junjie Xing; Ivan Cokic; Konstantin G Birukov
Journal:  Transl Res       Date:  2010-01       Impact factor: 7.012

5.  Cytosolic group IVa phospholipase A2 mediates IL-8/CXCL8-induced transmigration of human polymorphonuclear leukocytes in vitro.

Authors:  Angelo Y Meliton; Nilda M Muñoz; Lucille N Meliton; David C Binder; Christopher M Osan; Xiangdong Zhu; Steven M Dudek; Alan R Leff
Journal:  J Inflamm (Lond)       Date:  2010-03-18       Impact factor: 4.981

6.  RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.

Authors:  Richard T Clements; Fred L Minnear; Harold A Singer; Rebecca S Keller; Peter A Vincent
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-10-08       Impact factor: 5.464

7.  Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks beta 2-integrin adhesion in neutrophils.

Authors:  Angelo Y Meliton; Nilda M Munoz; Xiangdong Zhu; Alan R Leff
Journal:  J Leukoc Biol       Date:  2007-10-30       Impact factor: 4.962

8.  Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27.

Authors:  Melissa C Garcia; Denise M Ray; Brad Lackford; Mark Rubino; Kenneth Olden; John D Roberts
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

9.  IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins.

Authors:  Aaron B Waxman; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

10.  Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo.

Authors:  Stephanie Nonas; Anna A Birukova; Panfeng Fu; Jungjie Xing; Santipongse Chatchavalvanich; Valery N Bochkov; Norbert Leitinger; Joe G N Garcia; Konstantin G Birukov
Journal:  Crit Care       Date:  2008-01-24       Impact factor: 9.097

View more
  34 in total

1.  Factors controlling vascular permeability: transmitting mechanical signals. Focus on "Mechanical induction of group V phospholipase A₂ causes lung inflammation and acute lung injury".

Authors:  Judy Creighton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

2.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

Review 3.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

4.  The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation.

Authors:  Arnold Johnson; Paul H Neumann; Jianya Peng; Janey James; Vincenzo Russo; Hunter MacDonald; Nancy Gertzberg; Carlos Feleder
Journal:  J Neuroimmunol       Date:  2015-07-06       Impact factor: 3.478

Review 5.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

6.  Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase.

Authors:  Kristina R Wilhelm; Esra Roan; Manik C Ghosh; Kaushik Parthasarathi; Christopher M Waters
Journal:  FEBS J       Date:  2013-12-24       Impact factor: 5.542

7.  Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.

Authors:  E Letsiou; A N Rizzo; S Sammani; P Naureckas; J R Jacobson; J G N Garcia; S M Dudek
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

8.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.

Authors:  Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

Review 9.  Coming to terms with tissue engineering and regenerative medicine in the lung.

Authors:  Y S Prakash; Daniel J Tschumperlin; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

Review 10.  Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities.

Authors:  Jurjan Aman; Ester M Weijers; Geerten P van Nieuw Amerongen; Asrar B Malik; Victor W M van Hinsbergh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.